American Association for Cancer Research Archives

VICC researchers featured at AACR Annual Meeting

Apr. 8, 2021—Researchers from Vanderbilt-Ingram Cancer Center will have a robust presence during the first session of the American Association for Cancer Research (AACR) Annual Meeting, April 10-15, as presenters, panelists and authors.

From left, Kimryn Rathmell, MD, PhD, Bradley Reinfeld, Matthew Madden and Jeffrey Rathmell, PhD, have discovered that immune cells — not cancer cells — are the major glucose consumers in the tumor microenvironment, upending a century-old observation.

Study revises understanding of cancer metabolism

Apr. 7, 2021—Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years.

A childhood role model helped inspire Portia Thomas to pursue a career in medicine and research.

Diversity role model inspires career path

Oct. 1, 2020—Portia Thomas grew up in Doerun, Georgia, a small, rural city named by pioneer hunters as a place with “a perfect doe run,” where the population has hovered around 800 people for the past 30 years. A childhood impression lifted her aspirations beyond her hometown and inspired her to pursue a career as a physician-scientist.

Early-career investigators

Mar. 12, 2020—Henry Henderson, PhD, was one of 16 researchers selected to participate in the American Association for Cancer Research’s Early-Career Investigator Hill Day on Feb. 27 in Washington, D.C. While there, he met with U.S. Sen. Marsha Blackburn and discussed funding for the National Institutes of Health and the National Cancer Institute with a member of the senator’s health policy staff.

VUMC study sheds light on gastric cancer development

Jan. 16, 2020—VUMC researchers have created the world’s first laboratory model of precancerous changes in the lining of the stomach, a scientific tour de force that is helping to unlock the mysteries of gastric cancer development.

Single-cell study of tumor samples

Oct. 26, 2016—A new method for analyzing cells in fixed biopsy tissues from patients by guide personalized treatment strategies for cancer.

VUMC’s Arteaga named a fellow of the AACR Academy

Feb. 26, 2015—Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named a fellow of the AACR Academy.

New technique tracks breast cancer subtypes, treatment effectiveness

Oct. 17, 2013—A group of Vanderbilt researchers has used laser technology and a custom-built multiphoton microscope to distinguish breast cancer subtypes and determine if specific therapies are working against the cancer cells in as little as two days.

Study finds state-to-state variation in benign lung disease diagnosis

May. 30, 2013—A study led by Vanderbilt University Medical Center investigators found that rates of benign lung disease diagnosis varied widely by state following surgery for lung cancer.

VU’s Arteaga to lead American Association for Cancer Research

Apr. 4, 2013—Carlos Arteaga, M.D., professor of Medicine and Cancer Biology at Vanderbilt, has been elected president-elect of the American Association for Cancer Research for 2013-2014.

Vanderbilt identifies genes linked to breast cancer chemo resistance

Jun. 11, 2012—A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.